The megencephaly mouse has disturbances in the insulin-like growth factor (IGF) system

Molecular Brain Research

Volumn 72, Issue 1, 1999, Pages 80-88

  Petersson, Susanna ^a   Sandberg Nordqvist, Ann Christin ^a   Schalling, Martin ^a   Lavebratt, Catharina ^a  

^a Center for Molecular Medicine   (Sweden)

Author keywords

Brain; Insulin like growth factor binding protein; mceph mceph; Megalencephaly; Megencephaly mutant mouse; mRNA in situ hybridization

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MYELIN; PROTEOLIPID PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN GROWTH; CONTROLLED STUDY; CORPUS CALLOSUM; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MACROCEPHALY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PYRIFORM CORTEX;

ABNORMALITIES; AMYGDALA; ANIMALS; BODY WEIGHT; BRAIN; CORPUS CALLOSUM; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LIVER; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; RNA, MESSENGER;

EID: 0345493762     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00211-9     Document Type: Article

References (54)

1. Ayer-LeLievre C., Ståhlbom P.A., Sara V.R. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development. 111:1991;105-115.
2. Beck K.D., Powell-Braxton L., Widmer H.-R., Valverde J., Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
3. Beilharz E.J., Klempt N.D., Klempt M., Sirimanne E., Dragunow M., Gluckman P.D. Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Mol. Brain Res. 18:1993;209-215.
4. Bell G.I., Stempien M.M., Fong N.M., Rall L.B. Sequences of liver cDNA encoding two different mouse insulin-like growth factor I precursors. Nucleic Acids Res. 14:1986;7873-7882.
5. Bethel C.R., Vitullo J.C., Miller R.E., Aron D.C. Molecular cloning of mouse insulin-like growth factor binding protein 4 (IGFBP-4) cDNA and expression of a fusion protein with IGF activity. Biochem. Mol. Biol. Int. 34:1994;385-392.
6. Bondy C., Werner H., Roberts C.T. Jr., LeRoith D. Cellular pattern of type-1 insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors 1 and 2. Neuroscience. 46:1992;909-923.
7. Booth B.A., Bar R.S., Boes M., Dake B.L., Bayne M., Cascieri M. Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells. Endocrinology. 127:1990;2630-2638.
8. Burgunder J.-M., Young W.S. III The distribution of thalamic projection neurons containing cholecystokinin messenger RNA, using in situ hybridization histochemistry and retrograde labeling. Mol. Brain Res. 464:1988;179-189.
9. Canalis E., Gabbitas B. Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures. J. Biol. Chem. 270:1995;10771-10776.
10. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10:1993;729-740.
11. DeChiara T.M., Efstradiadis A., Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor 2 gene disrupted by targeting. Nature. 345:1990;78-80.
12. Clemmons D.R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8:1997;45-62.
13. Cook J.L., Marcheselli V., Alam J., Deininger P.L., Bazan N.G. Temporal changes in gene expression following cryogenic rat brain injury. Mol. Brain Res. 55:1998;9-19.
14. Dai Z., Xing Y., Boney C.M., Clemmons D.R., D'Erecole A.J. Human insulin-like growth factor binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology. 135:1994;1316-1327.
15. Dernyck R., Jarret J.A., Chen E.Y., Goeddel D.V. The murine transforming growth factor-beta precursor. J. Biol. Chem. 261:1986;4377-4379.
16. Deschenes R.J., Lorenz L.J., Haun R.S., Roos B.A., Collier K.J., Dixon J.E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc. Natl. Acad. Sci. U.S.A. 81:1984;726-730.
17. Donahue L.R., Cook S.A., Johnson K.R., Bronson R.T., Davisson M.T. Megencephaly: a new mouse mutation on chromosome 6 that causes hypertrophy of the brain. Mamm. Genome. 7:1996;871-876.
18. Durham S.K., Riggs B.L., Conover C.A. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J. Clin. Endocrinol. Metab. 79:1994;1752-1758.
19. D'Ercole A.J., Ye P., Calikoglu A.S., Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13:1996;227-255.
20. Erondu N.E., Dake B.L., Moser D.R., Lin M., Boes M., Bar R.S. Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-1 and TGF-beta. Growth Regul. 6:1996;1-9.
21. Garcia-Estrada J., Garcia-Segura L.M., Torres-Aleman I. Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res. 592:1992;343-347.
22. Gluckman P.D., Guan J., Williams C., Scheepens A., Zhang R., Bennet L., Gunn A. Asphyxial brain injury - the role of the IGF system. Mol. Cell Endocrinol. 140:1998;95-99.
23. Gooskens R.H.J.M., Willemse J., Bijlsma J.B., Hanlo P.W. Megalencephaly: definition and classification. Brain Dev. 10:1988;1-7.
24. Hudson L.D., Berndt J.A., Puckett C., Kozak C.A., Lazzarini R.A. Abberant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1454-1458.
25. Iwarsson K., Norén L. Comparison of microenvironmental conditions in standard versus forced-air ventilated rodent filter-top cages. Scand. J. Lab. Anim. Sci. 19:1992;167-173.
26. James P.L., Jones S.B., Busby W.H., Clemmons D.R., Rotwein P. A highly conserved insulin-like growth factor (IGFBP-5) is expressed during myoblast differentiation. J. Biol. Chem. 268:1993;22305-22312.
27. Kelley K.M., Oh Y., Garosky S.E., Gucev Z., Matsumoto T., Hwa V., Ng L., Simpson D.M., Rosenfeld R.G. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28:1996;619-637.
28. Klempt M., Klempt M.D., Gluckman P.D. Hypoxia and hypoxia/ischemia affect the expression of insulin-like growth factor binding protein 2 in the developing rat brain. Mol. Brain Res. 17:1993;347-350.
29. Lavebratt C., Inzunza J., Petersson S., Iwarsson K., Schalling M., Ährlund-Richter L. Ovary transplantation method resulting in high reproductive performance in mice. Scand. J. Lab. Anim. Sci. 25:1998;53-61.
30. Lee W.-H., Micheils K.M., Bondy C.A. Insulin-like growth factors in response to cerebral ischemia. Mol. Cell. Neurosci. 3:1992;36-43.
31. Li X., Williams M., Barlett W.P. Induction of IGF-1 mRNA expression following traumatic injury to the postnatal brain. Mol. Brain Res. 57:1998;92-96.
32. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell. Biol. 117:1992;395-400.
33. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:1993;59-72.
34. Logan A., Frautschy S.A., Gonzalez A.M., Sporn M.B., Baird A. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
35. Lorber J., Priestley B.L. Children with large heads: a practical approach to diagnosis in 557 children, with special reference to 109 children with megalencephaly. Dev. Med. Child Neurol. 23:1981;494-504.
36. Löppönen T., Saukkonen A.-L., Serlo W., Tapanainen P., Ruokonen A., Lanning P., Knip P. Pituitary function in children with hydrocephalus before the first shunting operation. Eur. J. Endocrinol. 138:1998;170-175.
37. Menouny M., Binoux M., Babajko S. Role of insulin growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-beta and retinoic acid. Endocrinology. 138:1997;683-690.
38. Ni W., Rajkumar K., Nagy J.I., Murphy L.J. Impaired brain development and reduced response to injury in transgenic mice expressing IGF binding protein-1. Brain Res. 769:1997;97-107.
39. O'Dell S., Day I.N.M. Insulin-like growth factor II (IGF-II). Int. J. Biochem. Cell Biol. 30:1998;767-771.
40. Oh Y. IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res. Treat. 47:1998;283-293.
41. S. Petersson, N.L. Pedersen, M. Schalling, C. Lavebratt, Primary megalencephaly at birth and low intelligence level. Neurology, in press.
42. Pintar J.E., Cerro J.A., Wood T.L. Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development. Horm. Res. 45:1996;172-177.
43. Rimaniol A.C., Lekieffre D., Serrano A., Masson A., Benavides J., Zavala F. Biphasic transforming growth factor-beta production flanking the pro-inflammatory cytokine response in cerebral trauma. NeuroReport. 7:1995;133-136.
44. Rotwein P., Hall L.J. Evolution of Insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudoexons. DNA Cell Biol. 9:1990;725-735.
45. Sandberg Nordqvist A.-C., von Holst H., Holmin S., Sara V.R., Bellander B.-M., Schalling M. Increase of insulin-like growth factor (IGF)-1, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Mol. Brain Res. 38:1996;285-293.
46. Schoenle E.J., Hasselbacher G.K., Briner J., Janzer R.C., Gammeltoft S., Humbel R., Prader M.D. Elevated concentrations of IGFII in brain tissue from an infant with macrencephaly. J. Pediatr. 108:1986;737-740.
47. Schuller A.G., Groffen C., van Neck J.W., Zwarthoff E.C., Drop S.L. cDNA cloning and expression of the six mouse insulin-like growth factor binding proteins. Mol. Cell. Endocrinol. 104:1994;57-66.
48. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3:1991;243-266.
49. Tso J.Y., Sun X.H., Kao T.H., Reece K.S., Wu R. Isolation and characterization of glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:1985;2485-2502.
50. Valentinis B., Bhala A., DeAngelis T., Baserga R., Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-1 receptor gene. Mol. Endocrinol. 9:1995;361-367.
51. Wada J., Liu Z.Z., Alvarez K., Kumar A., Wallner E., Makino H., Kanwar Y.S. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor 1 receptor and the role of the receptor in metanephric development. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10360-10364.
52. Wahlsten D. Heritable aspects of anomalous myelinated fibre tracts in the forebrain of the laboratory mouse. Brain Res. 68:1974;1-18.
53. Wood T.L., Brown A.L., Rechler M.M., Pintar J.E. The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-2 in the midgestional rat embryo. Mol. Endocrinol. 4:1990;1257-1263.
54. Ye P., Carson J., D'Ercole A.J. In vivo actions of insulin-like growth factor I (IGF-I) on brain myelination; studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15:1995;7344-7356.